Cargando…

RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer

BACKGROUND: RNA binding proteins (RBPs) play an important role in regulating the metabolism of target RNAs. Aberrant expression of RBPs plays a vital role in the initiation and development of many cancers. The RBM family, which has the conserved RNA binding motif RNP1 and RNP2, shares the similar fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xi, Hu, Yue, Wu, Jing, Shi, Liang, Zhu, Lei, Xi, Pei-Wen, Wei, Ji-Fu, Ding, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278172/
https://www.ncbi.nlm.nih.gov/pubmed/30514345
http://dx.doi.org/10.1186/s13046-018-0968-z
_version_ 1783378303935053824
author Sun, Xi
Hu, Yue
Wu, Jing
Shi, Liang
Zhu, Lei
Xi, Pei-Wen
Wei, Ji-Fu
Ding, Qiang
author_facet Sun, Xi
Hu, Yue
Wu, Jing
Shi, Liang
Zhu, Lei
Xi, Pei-Wen
Wei, Ji-Fu
Ding, Qiang
author_sort Sun, Xi
collection PubMed
description BACKGROUND: RNA binding proteins (RBPs) play an important role in regulating the metabolism of target RNAs. Aberrant expression of RBPs plays a vital role in the initiation and development of many cancers. The RBM family, which has the conserved RNA binding motif RNP1 and RNP2, shares the similar function in RNA processing and RBMS2 is a member of them. P21, also named CDKN1A, promotes cell cycle arrest and plays an important role in halting cell proliferation. In our study, we identified RBMS2 as a tumor suppressor in breast cancer. It inhibited the proliferation of breast cancer by positively regulating the stability of P21 mRNA in posttranscriptional way. METHODS: TCGA was used to identify differentially expressed RBPs in breast cancer. The effect of RBMS2 on breast cancer proliferation was evaluated in vitro using CCK-8 assays, colony formation assays and cell-cycle assays and the in vivo effect was investigated using a mouse tumorigenicity model. The main pathway and genes regulated by RBMS2 was detected by RNA sequencing. The RNA immunoprecipitation combined with dual-luciferase reporter assay were conducted to testify the direct binding between RBMS2 and P21. Rescue assay was used to detect P21 as the main target of RBMS2. RESULTS: The expression of RBMS2 was lower in breast cancer compared with normal tissues and was a favorable biomarker in breast cancer. RBMS2 inhibited the proliferation of breast cancer and P21 was the main target of RBMS2. RBMS2 stabilized the mRNA of P21 by directly binding to the AU-rich element of 3′-UTR region. Anti-proliferation activity induced by overexpression of RBMS2 was rescued by interfering with the expression of P21. CONCLUSION: In conclusion, RBMS2 acted as a tumor suppressor in breast cancer and positively regulated the expression of P21 by stabilizing its mRNA. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-018-0968-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6278172
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62781722018-12-10 RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer Sun, Xi Hu, Yue Wu, Jing Shi, Liang Zhu, Lei Xi, Pei-Wen Wei, Ji-Fu Ding, Qiang J Exp Clin Cancer Res Research BACKGROUND: RNA binding proteins (RBPs) play an important role in regulating the metabolism of target RNAs. Aberrant expression of RBPs plays a vital role in the initiation and development of many cancers. The RBM family, which has the conserved RNA binding motif RNP1 and RNP2, shares the similar function in RNA processing and RBMS2 is a member of them. P21, also named CDKN1A, promotes cell cycle arrest and plays an important role in halting cell proliferation. In our study, we identified RBMS2 as a tumor suppressor in breast cancer. It inhibited the proliferation of breast cancer by positively regulating the stability of P21 mRNA in posttranscriptional way. METHODS: TCGA was used to identify differentially expressed RBPs in breast cancer. The effect of RBMS2 on breast cancer proliferation was evaluated in vitro using CCK-8 assays, colony formation assays and cell-cycle assays and the in vivo effect was investigated using a mouse tumorigenicity model. The main pathway and genes regulated by RBMS2 was detected by RNA sequencing. The RNA immunoprecipitation combined with dual-luciferase reporter assay were conducted to testify the direct binding between RBMS2 and P21. Rescue assay was used to detect P21 as the main target of RBMS2. RESULTS: The expression of RBMS2 was lower in breast cancer compared with normal tissues and was a favorable biomarker in breast cancer. RBMS2 inhibited the proliferation of breast cancer and P21 was the main target of RBMS2. RBMS2 stabilized the mRNA of P21 by directly binding to the AU-rich element of 3′-UTR region. Anti-proliferation activity induced by overexpression of RBMS2 was rescued by interfering with the expression of P21. CONCLUSION: In conclusion, RBMS2 acted as a tumor suppressor in breast cancer and positively regulated the expression of P21 by stabilizing its mRNA. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-018-0968-z) contains supplementary material, which is available to authorized users. BioMed Central 2018-12-04 /pmc/articles/PMC6278172/ /pubmed/30514345 http://dx.doi.org/10.1186/s13046-018-0968-z Text en © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Sun, Xi
Hu, Yue
Wu, Jing
Shi, Liang
Zhu, Lei
Xi, Pei-Wen
Wei, Ji-Fu
Ding, Qiang
RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer
title RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer
title_full RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer
title_fullStr RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer
title_full_unstemmed RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer
title_short RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer
title_sort rbms2 inhibits the proliferation by stabilizing p21 mrna in breast cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278172/
https://www.ncbi.nlm.nih.gov/pubmed/30514345
http://dx.doi.org/10.1186/s13046-018-0968-z
work_keys_str_mv AT sunxi rbms2inhibitstheproliferationbystabilizingp21mrnainbreastcancer
AT huyue rbms2inhibitstheproliferationbystabilizingp21mrnainbreastcancer
AT wujing rbms2inhibitstheproliferationbystabilizingp21mrnainbreastcancer
AT shiliang rbms2inhibitstheproliferationbystabilizingp21mrnainbreastcancer
AT zhulei rbms2inhibitstheproliferationbystabilizingp21mrnainbreastcancer
AT xipeiwen rbms2inhibitstheproliferationbystabilizingp21mrnainbreastcancer
AT weijifu rbms2inhibitstheproliferationbystabilizingp21mrnainbreastcancer
AT dingqiang rbms2inhibitstheproliferationbystabilizingp21mrnainbreastcancer